Correction of anemia by dapagliflozin in patients with type 2 diabetes
Bergur V. Stefánsson, Hiddo J.L. Heerspink, David C. Wheeler, C. David Sjöström, Peter J. Greasley, Peter Sartipy, Valerie A. Cain, Ricardo Correa‐Rotter
Topics & Concepts
DapagliflozinMedicineAnemiaType 2 diabetesKidney diseaseHemoglobinInternal medicineDiabetes mellitusPlaceboRenal functionErythropoietinGastroenterologyUrologyEndocrinologyPathologyAlternative medicineDiabetes Treatment and ManagementErythropoietin and Anemia TreatmentPancreatic function and diabetes